| scholarly article | Q13442814 |
| P2093 | author name string | Fu W | |
| Mihatsch MJ | |||
| Moch H | |||
| Sauter G | |||
| Gasser T | |||
| Kononen J | |||
| Wilber K | |||
| Schraml P | |||
| Struckmann K | |||
| Bednar R | |||
| P2860 | cites work | A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4 | Q24322196 |
| Regulation of p16CDKN2 expression and its implications for cell immortalization and senescence | Q24650807 | ||
| A cell cycle regulator potentially involved in genesis of many tumor types | Q28251933 | ||
| A novel p16INK4A transcript | Q28288161 | ||
| Tissue microarrays for high-throughput molecular profiling of tumor specimens | Q29618675 | ||
| Germline p16 mutations in familial melanoma | Q34059915 | ||
| Comprehensive allelotyping of human renal cell carcinomas using microsatellite DNA probes | Q34509847 | ||
| High-throughput tissue microarray analysis to evaluate genes uncovered by cDNA microarray screening in renal cell carcinoma | Q35786795 | ||
| Evaluation of the clonal relationship between primary and metastatic renal cell carcinoma by comparative genomic hybridization | Q35787295 | ||
| The CDKN2A (p16) gene and human cancer. | Q36437816 | ||
| Homozygous deletions within human chromosome band 9p21 in melanoma | Q37286548 | ||
| Functional reassessment of P16 variants using a transfection-based assay | Q40944770 | ||
| Molecular analysis of P16(Ink4)/CDKN2 and P15(INK4B)/MTS2 genes in primary human testicular germ cell tumors | Q41049285 | ||
| Mutational analysis of CDKN2 (CDK4I/MTS1) gene in tissues and cell lines of human prostate cancer | Q41332196 | ||
| Homozygous deletions within 9p21-p22 identify a small critical region of chromosomal loss in human malignant mesotheliomas | Q41520737 | ||
| Molecular differential diagnosis of renal cell carcinomas by microsatellite analysis | Q42803057 | ||
| Deletion map of chromosome 9 and p16 (CDKN2A) gene alterations in neuroblastoma. | Q42814171 | ||
| Haplotype analysis of two recurrent CDKN2A mutations in 10 melanoma families: evidence for common founders and independent mutations | Q44219747 | ||
| Analysis of the CDKN2A, CDKN2B and CDK4 genes in 48 Australian melanoma kindreds | Q46487546 | ||
| Genetic aberrations detected by comparative genomic hybridization are associated with clinical outcome in renal cell carcinoma. | Q46525301 | ||
| Inactivation of the von Hippel-Lindau (VHL) tumour suppressor gene and allelic losses at chromosome arm 3p in primary renal cell carcinoma: evidence for a VHL-independent pathway in clear cell renal tumourigenesis | Q47981361 | ||
| Loss of heterozygosity of microsatellite loci on chromosome 9p in astrocytic tumors and its prognostic implications | Q48909013 | ||
| Mutations associated with familial melanoma impair p16INK4 function. | Q52537796 | ||
| Deletion mapping of chromosome region 9p21-p22 surrounding the CDKN2 locus in melanoma. | Q53999927 | ||
| The Heidelberg classification of renal cell tumours. | Q55067278 | ||
| Contribution of Chromosome 9p21‐22 Deletion to the Progression of Human Renal Cell Carcinoma | Q55388589 | ||
| 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers | Q55480673 | ||
| Frequent loss of heterozygosity on chromosome 9 in adenocarcinoma and squamous cell carcinoma of the esophagus. | Q55481521 | ||
| Haplotype analysis of two recurrentCDKN2A mutations in 10 melanoma families: Evidence for common founders and independent mutations | Q56438205 | ||
| Mutations in the CDKN2A ( p16INK4a ) gene in microdissected sporadic primary melanomas | Q57664941 | ||
| Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16 | Q59082348 | ||
| Histopathology and classification of renal cell tumors (adenomas, oncocytomas and carcinomas). The basic cytological and histopathological elements and their use for diagnostics | Q69578343 | ||
| Genomic alterations and instabilities in renal cell carcinomas and their relationship to tumor pathology | Q70786914 | ||
| Accumulation of p16CDKN2A in response to ultraviolet irradiation correlates with late S-G(2)-phase cell cycle delay | Q71129121 | ||
| Frequency of homozygous deletion at p16/CDKN2 in primary human tumours | Q71721193 | ||
| Frequent allele loss on 9p21-22 defines a smallest common region in the vicinity of the CDKN2 gene in sporadic breast cancer | Q71722021 | ||
| Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers | Q71729088 | ||
| Methylation of the 5' CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing | Q71729092 | ||
| Chromosome-9 loss detected by fluorescence in situ hybridization in bladder cancer | Q71891260 | ||
| Rates of p16 (MTS1) mutations in primary tumors with 9p loss | Q72041274 | ||
| Homozygous deletions of 9p21 in primary human bladder tumors detected by comparative multiplex polymerase chain reaction | Q72313814 | ||
| Localization of tumor suppressor loci on chromosome 9 in primary human renal cell carcinomas | Q72388328 | ||
| MTS1/CDKN2 gene mutations are rare in primary human astrocytomas with allelic loss of chromosome 9p | Q72529989 | ||
| Frequent loss of chromosome 9 in human primary non-small cell lung cancer | Q72769107 | ||
| Increased expression of cyclin-dependent kinase inhibitor 2 (CDKN2A) gene product P16INK4A in ovarian cancer is associated with progression and unfavourable prognosis | Q73081846 | ||
| Alteration of p16 and p15 genes in common epithelial ovarian tumors | Q73302855 | ||
| Chromosome 9p deletions in invasive and noninvasive nonfunctional pituitary adenomas: the deleted region involves markers outside of the MTS1 and MTS2 genes | Q73470634 | ||
| Loss of Heterozygosity at Chromosome 9p21 in Primary Neuroblastomas: Evidence for Two Deleted Regions | Q73496858 | ||
| A comparison of p53 and p16 expression in human tumor cells treated with hyperthermia or ionizing radiation | Q73503269 | ||
| Allelic loss at the D9S171 locus on chromosome 9p13 is associated with progression of papillary renal cell carcinoma | Q73504522 | ||
| Homozygous deletions at 9p21 in childhood acute lymphoblastic leukemia detected by microsatellite analysis | Q73767278 | ||
| G1 control gene status is frequently altered in resectable non-small cell lung cancer | Q73841999 | ||
| Loss of heterozygosity at chromosomes 8p, 9p, and 14q is associated with stage and grade of non-papillary renal cell carcinomas | Q73923938 | ||
| 9p21 deletion correlates with recurrence in head and neck cancer | Q74250907 | ||
| Retinoblastoma and p16 proteins in mammary carcinoma: their relationship to cyclin D1 and histopathological parameters | Q74292669 | ||
| CDKN2A mutations in multiple primary melanomas | Q74357667 | ||
| Homozygous deletion of the p16INK4a and the p15INK4b tumour suppressor genes in a subset of human sporadic cutaneous malignant melanoma | Q74425282 | ||
| Infrequent mutation of the p16/MTS1 gene and overexpression of cyclin-dependent kinase 4 in human primary soft-tissue sarcoma | Q74490616 | ||
| Overexpression of the cyclin-dependent kinase inhibitor p16 is associated with tumor recurrence in human prostate cancer | Q77827926 | ||
| Response | Q94596609 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 593-601 | |
| P577 | publication date | 2001-02-01 | |
| P1433 | published in | The American Journal of Pathology | Q4744259 |
| P1476 | title | CDKNA2A mutation analysis, protein expression, and deletion mapping of chromosome 9p in conventional clear-cell renal carcinomas: evidence for a second tumor suppressor gene proximal to CDKN2A. | |
| P478 | volume | 158 |
| Q55298720 | Aberrations of the p14(ARF) and p16(INK4a) genes in renal cell carcinomas. |
| Q28253911 | An automated procedure to identify biomedical articles that contain cancer-associated gene variants |
| Q41815800 | Analysis of p16 expression and allelic imbalance / loss of heterozygosity of 9p21 in cutaneous squamous cell carcinomas |
| Q38184386 | Biomarkers in renal cancer |
| Q91519122 | Chromosomal deletion of 9p21 is linked to poor patient prognosis in papillary and clear cell kidney cancer |
| Q34283721 | Chromosome 9p deletion in clear cell renal cell carcinoma predicts recurrence and survival following surgery |
| Q33220432 | Clonal divergence and genetic heterogeneity in clear cell renal cell carcinomas with sarcomatoid transformation |
| Q36648942 | Cytogenetic alterations in ovarian clear cell carcinoma detected by comparative genomic hybridisation |
| Q38947910 | Downregulation of NDUFB6 due to 9p24.1-p13.3 loss is implicated in metastatic clear cell renal cell carcinoma |
| Q26785930 | Genetic and Chromosomal Aberrations and Their Clinical Significance in Renal Neoplasms |
| Q37401031 | Genome-wide profiling of chromosomal alterations in renal cell carcinoma using high-density single nucleotide polymorphism arrays |
| Q52544535 | INK4a-ARF alterations and p53 mutations in hepatocellular carcinomas. |
| Q37728343 | Kinase targets in renal-cell carcinomas: reassessing the old and discovering the new. |
| Q34695773 | Loss of chromosome 9p is an independent prognostic factor in patients with clear cell renal cell carcinoma |
| Q36730935 | Loss of heterozygosity and copy number abnormality in clear cell renal cell carcinoma discovered by high-density affymetrix 10K single nucleotide polymorphism mapping array |
| Q33710257 | Metastatic renal cell carcinoma with undetectable renal mass presenting as lymphadenopathy |
| Q54792472 | Multipoint methylation and expression analysis of tumor suppressor genes in human renal cancer cells. |
| Q28298079 | Pathological characterization of Kank in renal cell carcinoma |
| Q37349768 | Patterns of gene expression and copy-number alterations in von-hippel lindau disease-associated and sporadic clear cell carcinoma of the kidney |
| Q35792041 | Relevance of nuclear and cytoplasmic von hippel lindau protein expression for renal carcinoma progression. |
| Q37579066 | Significance of CDKN2A gene A148T variant in patients with bladder cancer. |
| Q33616134 | Significance of chromosome 9p status in renal cell carcinoma: a systematic review and quality of the reported studies. |
| Q36872295 | The VHL/HIF axis in clear cell renal carcinoma |
| Q39341646 | Tumour suppressor gene (CDKNA2) status on chromosome 9p in resected renal tissue improves prognosis of localised kidney cancer |
| Q53327323 | [Exploration of tumor suppressors p16INK4a and p14ARF in oral leukoplakias]. |
Search more.